Takeda Pharmaceutical Company Limited (NYSE:TAK) Q4 2024 Earnings Call Transcript May 9, 2025
Christopher O’Reilly: Thank you very much for taking time out of their busy schedule to join our earnings announcement for FY ’24 for Takeda. I’m the master of ceremony, Head of IR. My name is O’Reilly. Thank you for this opportunity. [Operator Instructions] And before starting, I’d like to remind everyone that we’ll be discussing forward-looking statements within the meaning of the Private...
